Stocktwits37d agobullish
CRNX Stock Soars Nearly 100% After-Hours On Vertex's $10B AcquisitionThe deal values Crinetics at $85 per share in cash, representing a potential upside of about 100% from the stock’s closing price on Monday.
Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
317last 24h
2132last 7d
379● bullish (7d)
183● bearish (7d)
204publishers
Investing.com37d agobullish
Crinetics soars on $10B acquisition by VertexInvesting.com -- Vertex Pharmaceuticals Incorporated announced Monday it will acquire Crinetics Pharmaceuticals, Inc. for $85.00 per share in cash, representing a total equity value of approximately $10.0 billion, or approximately $8.8 billion net of estimated cash acquired.